[ad_1]
“According to today’s plans and preliminary vaccine figures available today, … the modern vaccine will continue to be vaccinated with the first vaccine, the Pfizer vaccine will only be left for the second vaccine until the second week of February,” he said on Friday a spokeswoman for the ministry.
He emphasized that this plan is based on the information currently available from the provider and is subject to change depending on the circumstances.
“Starting the second week of February, some safe amounts of Pfizer vaccine will be used for the first vaccination and to continue with the booster shot,” Šuksta said.
He confirmed that the booster vaccination with the second COVID-19 vaccine for those who were vaccinated first will begin on Sunday.
Lithuanian municipalities have been informed that due to the doubling of vaccine deliveries, no municipality will receive doses for the first vaccination in the next three weeks.
“The amounts of vaccine that are already delivered to the municipalities do not change, it is requested that they be used promptly. Other employees of outpatient health care institutions had to be vaccinated with the newly received doses of the vaccine, ”reports the Šiauliai city municipality.
As the Health Ministry previously announced on Friday, the companies announced late Thursday that 54,405 doses of the vaccine would be delivered instead of 108,810 doses over the next four weeks.
Based on available data, Pfizer has temporarily reduced the supply of COVID-19 while reviewing its technology processes.
According to the ministry, a representative from BioNTech and Pfizer assures that the number of doses of vaccines that will be delivered later will increase. The manufacturer promises to provide information on the exact number of vaccines to be administered in the near future.
Vaccination priorities will not change and vaccination will continue as planned, only for longer than planned.
According to the ministry, the expected delivery volumes are reduced for all countries of the European Union.
The total quantity of BioNTech and Pfizer vaccines ordered by Lithuania is 3.1 million. and will not change as a result of this temporary reduction in supply.
On December 27, CONID-19, developed by BioNTech and Pfizer at five central treatment facilities in the country, will be the first to be vaccinated.
This vaccine is administered twice with an interval of three weeks after the first vaccination and adequate protection of the immune system is achieved one week after the second vaccination.
The first physicians to work with COVID-19 patients.
According to the Department of Statistics, 38 thousand people have been vaccinated with the first dose of the vaccine in Lithuania. The second dose has not started yet.
[ad_2]
